PKM and cancer: The upregulation of PKM2 is common in several types of cancer and contributes to a switch to glycolytic metabolism, reflecting the modulation of PKM1 and PKM2 ratio by alternative splicing to determine the choice between aerobic glycolysis and mitochondrial oxidative phosphorylation in response to metabolic stress.